Amphastar Pharmaceuticals Inc.

AMPH | NDAQ

Overview

Corporate Details

ISIN(s):: US03209R1032 (+3 more)
LEI:: 54930055TH0ZLSAQMJ38
Country:: United States of America
Address:: 850 NEW BURTON ROAD, 19904 DOVER
Website:: https://amphastar.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Amphastar Pharmaceuticals Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-03 00:00	Investor Presentation Wells Fargo Healthcare Presentation	English	3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Apontis Pharma AG German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.	Germany	APPH
Arctic Bioscience Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.	Norway	ABS
ArcticZymes Technologies Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.	Norway	AZT
ARECOR THERAPEUTICS PLC Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.	United Kingdom	AREC
argenx SE Develops first-in-class antibody therapies for severe autoimmune diseases.	Netherlands	1AE
ASKA Pharmaceutical Holdings CO., Ltd.	Japan	4886
Astellas Pharma Inc.	Japan	4503
AstraZeneca PLC A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.	United Kingdom	AZN
Bachem Holding AG A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.	Switzerland	BANB
Basilea Pharmaceutica AG Develops and commercializes anti-infective drugs for severe bacterial and fungal infections.	Switzerland	BSLN